Sichuan Yuansheng Biological Pharmaceutical

Sichuan Yuansheng Biological Pharmaceutical is a Chinese pharmaceutical company based in Chengdu that specializes in the development and manufacturing of biochemical drugs for orthopedic and neurological conditions. The company is most recognized for its flagship product, Compound Chondroitin Sulfate Injection, marketed under the brand name Aisheng, which is widely used to treat osteoarthritis and various forms of joint and nerve pain. Operating from a GMP-certified facility, Yuansheng integrates research, production, and marketing to maintain a strong presence in the domestic Chinese market. The firm focuses on providing effective therapeutic solutions for degenerative bone diseases and chronic pain management through high-quality biochemical formulations.